144 related articles for article (PubMed ID: 15222690)
1. No major association of ApoE genotype with disease characteristics and MRI findings in multiple sclerosis.
Zwemmer JN; van Veen T; van Winsen L; van Kamp GJ; Barkhof F; Polman CH; Uitdehaag BM
Mult Scler; 2004 Jun; 10(3):272-7. PubMed ID: 15222690
[TBL] [Abstract][Full Text] [Related]
2. Association of apolipoprotein E and myeloperoxidase genotypes to clinical course of familial and sporadic multiple sclerosis.
Zakrzewska-Pniewska B; Styczynska M; Podlecka A; Samocka R; Peplonska B; Barcikowska M; Kwiecinski H
Mult Scler; 2004 Jun; 10(3):266-71. PubMed ID: 15222689
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E genotype does not associate with disease severity measured by Multiple Sclerosis Severity Score.
Guerrero AL; Laherrán E; Gutiérrez F; Martín-Polo J; Iglesias F; Alcázar C; Peralta J; Rostami P
Acta Neurol Scand; 2008 Jan; 117(1):21-5. PubMed ID: 17883422
[TBL] [Abstract][Full Text] [Related]
4. APOE epsilon variation in multiple sclerosis susceptibility and disease severity: some answers.
Burwick RM; Ramsay PP; Haines JL; Hauser SL; Oksenberg JR; Pericak-Vance MA; Schmidt S; Compston A; Sawcer S; Cittadella R; Savettieri G; Quattrone A; Polman CH; Uitdehaag BM; Zwemmer JN; Hawkins CP; Ollier WE; Weatherby S; Enzinger C; Fazekas F; Schmidt H; Schmidt R; Hillert J; Masterman T; Hogh P; Niino M; Kikuchi S; Maciel P; Santos M; Rio ME; Kwiecinski H; Zakrzewska-Pniewska B; Evangelou N; Palace J; Barcellos LF
Neurology; 2006 May; 66(9):1373-83. PubMed ID: 16682670
[TBL] [Abstract][Full Text] [Related]
5. APOE genotypes and disease severity in multiple sclerosis.
Masterman T; Zhang Z; Hellgren D; Salter H; Anvret M; Lilius L; Lannfelt L; Hillert J
Mult Scler; 2002 Apr; 8(2):98-103. PubMed ID: 11990879
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein genotype does not influence MS severity, cognition, or brain atrophy.
van der Walt A; Stankovich J; Bahlo M; Taylor BV; van der Mei IA; Foote SJ; Kilpatrick TJ; Rubio JP; Butzkueven H
Neurology; 2009 Sep; 73(13):1018-25. PubMed ID: 19786693
[TBL] [Abstract][Full Text] [Related]
7. Association of apolipoprotein E genotypes with prognosis in multiple sclerosis.
Tamam Y; Tasdemir N; Yalman M; Tamam B
Eur Rev Med Pharmacol Sci; 2011 Oct; 15(10):1122-30. PubMed ID: 22165672
[TBL] [Abstract][Full Text] [Related]
8. Influence of apolipoprotein E epsilon4 genotype on brain tissue integrity in relapsing-remitting multiple sclerosis.
De Stefano N; Bartolozzi ML; Nacmias B; Zipoli V; Mortilla M; Guidi L; Siracusa G; Sorbi S; Federico A; Amato MP
Arch Neurol; 2004 Apr; 61(4):536-40. PubMed ID: 15096402
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E polymorphisms status in Iranian patients with multiple sclerosis.
Rafiei M; Zarif Yeganeh M; Sheikholeslami S; Gozalpour E; Ghaffarpour M; Hedayati M
J Neurol Sci; 2012 Sep; 320(1-2):22-5. PubMed ID: 22698480
[TBL] [Abstract][Full Text] [Related]
10. The relationship of APOE genetic polymorphism with susceptibility to multiple sclerosis and its clinical phenotypes in Kuwaiti Arab subjects.
Al-Shammri S; Fatania H; Al-Radwan R; Akanji AO
Clin Chim Acta; 2005 Jan; 351(1-2):203-7. PubMed ID: 15563891
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E epsilon 4 is associated with rapid progression of multiple sclerosis.
Fazekas F; Strasser-Fuchs S; Kollegger H; Berger T; Kristoferitsch W; Schmidt H; Enzinger C; Schiefermeier M; Schwarz C; Kornek B; Reindl M; Huber K; Grass R; Wimmer G; Vass K; Pfeiffer KH; Hartung HP; Schmidt R
Neurology; 2001 Sep; 57(5):853-7. PubMed ID: 11552016
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E genotype does not influence the progression of multiple sclerosis.
Savettieri G; Andreoli V; Bonavita S; Cittadella R; Caltagirone C; Fazio MC; Girlanda P; Le Pira F; Liguori M; Logroscino G; Lugaresi A; Nocentini U; Reggio A; Salemi G; Serra P; Tedeschi G; Toma L; Trojano M; Valentino P; Quattrone A
J Neurol; 2003 Sep; 250(9):1094-8. PubMed ID: 14504972
[TBL] [Abstract][Full Text] [Related]
13. Involvement of apolipoprotein E in multiple sclerosis: absence of remyelination associated with possession of the APOE epsilon2 allele.
Carlin C; Murray L; Graham D; Doyle D; Nicoll J
J Neuropathol Exp Neurol; 2000 May; 59(5):361-7. PubMed ID: 10888365
[TBL] [Abstract][Full Text] [Related]
14. Association between apolipoprotein E gene polymorphism and the risk of multiple sclerosis: a meta-analysis of 6977 subjects.
Yin YW; Zhang YD; Wang JZ; Li BH; Yang QW; Fang CQ; Gao CY; Li JC; Zhang LL
Gene; 2012 Dec; 511(1):12-7. PubMed ID: 22982410
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms of apolipoprotein E; outcome and susceptibility in multiple sclerosis.
Weatherby SJ; Mann CL; Davies MB; Carthy D; Fryer AA; Boggild MD; Young C; Strange RC; Ollier W; Hawkins CP
Mult Scler; 2000 Feb; 6(1):32-6. PubMed ID: 10694843
[TBL] [Abstract][Full Text] [Related]
16. Apo E in multiple sclerosis and optic neuritis: the apo E-epsilon4 allele is associated with progression of multiple sclerosis.
Pinholt M; Frederiksen JL; Andersen PS; Christiansen M
Mult Scler; 2005 Oct; 11(5):511-5. PubMed ID: 16193886
[TBL] [Abstract][Full Text] [Related]
17. Apoliprotein E and multiple sclerosis: impact of the epsilon-4 allele on susceptibility, clinical type and progression rate.
Høgh P; Oturai A; Schreiber K; Blinkenberg M; Jørgensen OS; Ryder L; Paulson OB; Sørensen PS; Knudsen GM
Mult Scler; 2000 Aug; 6(4):226-30. PubMed ID: 10962542
[TBL] [Abstract][Full Text] [Related]
18. APOE ε4 is associated with exacerbation of cognitive decline in patients with multiple sclerosis.
Shi J; Tu JL; Gale SD; Baxter L; Vollmer TL; Campagnolo DI; Tyry TM; Zhuang Y; Kuniyoshi SM
Cogn Behav Neurol; 2011 Sep; 24(3):128-33. PubMed ID: 21945984
[TBL] [Abstract][Full Text] [Related]
19. No association of apolipoprotein E epsilon4 genotype with faster progression or less recovery of relapses in a Spanish cohort of multiple sclerosis.
Sedano MI; Calmarza P; Perez L; Trejo JM
Mult Scler; 2006 Feb; 12(1):13-8. PubMed ID: 16459715
[TBL] [Abstract][Full Text] [Related]
20. The impact of our genes: consequences of the apolipoprotein E polymorphism in Alzheimer disease and multiple sclerosis.
Fazekas F; Enzinger C; Ropele S; Schmidt H; Schmidt R; Strasser-Fuchs S
J Neurol Sci; 2006 Jun; 245(1-2):35-9. PubMed ID: 16631796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]